ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SPEC Inspecs Group Plc

72.50
-1.50 (-2.03%)
21 May 2024 - Closed
Delayed by 15 minutes
Inspecs Investors - SPEC

Inspecs Investors - SPEC

Share Name Share Symbol Market Stock Type
Inspecs Group Plc SPEC London Ordinary Share
  Price Change Price Change % Share Price Last Trade
-1.50 -2.03% 72.50 15:34:28
Open Price Low Price High Price Close Price Previous Close
74.00 69.50 74.00 72.50 74.00
more quote information »
Industry Sector
PERSONAL GOODS

Top Investor Posts

Top Posts
Posted at 10/5/2024 12:45 by masurenguy
After a 63% rise over the past 3 weeks some profit taking is inevitable !

As at 30 April 2024 the top 8 shareholders held circa two-thirds of the shares in issue.
Shareholder
Canaccord Genuity Group Inc: 18.3%
Robin Totterman: 18.3%
Downing: 7.3%
Liontrust Asset Management: 6.7%
Royal London Asset Management GIS Ltd: 4.4%
Stonehage Fleming: 3.9%
River Global Investors: 3.8%
Hargreaves Lansdown: 3.6%
Posted at 06/5/2024 21:35 by thebears1
I am recently again a shareholder of spec and the truth is I doubt the private investors on any of these threads will make a difference to the share price.My point is why are people so desperate for attention they feel the need to do it.If it does have a positive affect then I stand to gain
Posted at 17/4/2024 13:15 by dan_the_epic
You are absolutely spot on Tom

What has happened is they have taken garden shears to the forecasts, and forecasts today are much lower than before. They have proven themselves to be unreliable operators in terms of hitting broker forecasts and that has earned a red blotch and discount from many investors. That can change over time

The shares are not cheap in a vacuum. You need major earnings upgrades to get back to 100p you're not going to get there with these broker forecasts
Posted at 29/1/2024 15:16 by eagle eye
The editor at SCSW is a brilliant writer.
Can't fault the entertainment value each and every month.
Picking the winners and avoiding the losers is down to us.
Lots of institutional investors here, so it's not just PI's that have been caught out.
Posted at 29/1/2024 12:04 by bookbroker
Does this vertically integrated model work, this company went on a buying spree in last four years to build an entire design apparatus, so far the results have been derisory, looks like they will be writing down the value of assets if there is no material improvement. Some of these acquisitions have been a waste of time and money, no surprises there, but so far investors have been massively short-changed.
Posted at 29/1/2024 08:54 by bookbroker
Be inclined to agree, if ebitda expected to be £18m for Yr Ending 12/23 then maybe market just crushing the minnows. Efficiencies seem to be ongoing, not sure why Norville still not profitable, and not sure why they continue with the plant unless solely for R&D. I don’t think ebitda a reliable indicator of anything, but that is what accounting standards allow. Maybe this still work in progress, no consolation to investors at the outset!
Posted at 14/11/2023 08:40 by john09
New thread for sharewatchers. General chat about SCSW followed stocks so investors can discuss 2024 etc. No sharing of subscriber only information
Posted at 27/10/2023 11:45 by john09
How not to catch a falling knife . This inept less experienced investor bought at 87p and here he is down 20 p in the same month

oldboy14 Oct '23 - 10:38 - 956 of 980

cheeky 5k add this morning

oldboy1 13 Oct '23 - 09:04 - 958 of 980

added same again this morning. LTH will be rewarded on this one.
Posted at 29/9/2023 16:20 by seekinvalue
Depends on your small cap.
But if its going nowhere why haven't IR time.to.answer investor queries. If its not a company engaged with its investor base it doesn't auger well 🤷🏼‍♂️
Posted at 10/7/2023 08:22 by masurenguy
Some good progress is being made here to both capitalize on prior acquisitions and also to exploit the post-Covid market in both regular perscription products and sunglasses. There is plenty of scope for a shareprice recovery based upon the prior IPO and subsequent placing some 3 years ago.

"The Company has successfully raised £23.5m by way of a placing of 12,051,282 new Ordinary Shares with institutional and other investors at a price of 195p per share. In addition, 36,171,506 existing Ordinary Shares have been placed on behalf of Selling Shareholders at the Placing Price, raising gross proceeds of £70.5 m. The Company's market capitalisation on Admission is £138.0m." 27/02/20

"A total of 30,476,191 Placing Shares have been conditionally placed with new and existing investors at a price of 210p per share, representing a nil discount to the mid-market closing price on 18 November 2020. The Placing will raise gross proceeds of approximately £64m and will represent approximately 30.09% of the enlarged issued share capital of the Company following Admission." 19/11/20

"We have had a good performance in Q1 2023 and are ahead of the same period in 2022. This was driven by a rebound in our European markets and continued growth in other markets." 27/04/23.

Interims are due in early September.

Your Recent History

Delayed Upgrade Clock